| RS121912534 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |
| RS121912535 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |
| RS121912536 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell agenesis, Leydig cell agenesis |
| RS121912537 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell agenesis, Leydig cell agenesis |
| RS121912538 |
LHCGR
|
Health Risk |
Pathogenic |
Leydig cell agenesis, Leydig cell agenesis |
| RS121912539 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leydig cell agenesis, Gonadotropin-independent familial sexual precocity |
| RS121912540 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Gonadotropin-independent familial sexual precocity |
| RS121912541 |
HOXD13
|
Health Risk |
Pathogenic |
Synpolydactyly type 1, Synpolydactyly type 1 |
| RS121912542 |
HOXA13
|
Health Risk |
Pathogenic |
Hand-foot-genital syndrome, Hand-foot-genital syndrome |
| RS121912543 |
VSX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Microphthalmia, cataracts |
| RS121912545 |
VSX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Isolated microphthalmia 2, Microphthalmia |
| RS121912546 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS121912547 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS121912548 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS121912549 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS121912550 |
IMPDH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 10, Retinal dystrophy |
| RS121912552 |
IMPDH1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 10, Retinal dystrophy |
| RS121912553 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 11, Retinal dystrophy |
| RS121912554 |
IMPDH1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 11, Leber congenital amaurosis 11 |
| RS121912555 |
INSL3
|
Health Risk |
Pathogenic |
Cryptorchidism, Cryptorchidism |
| RS121912556 |
INSL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryptorchidism, Cryptorchidism |
| RS121912557 |
MYO6
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal dominant nonsyndromic hearing loss 22 |
| RS121912558 |
MYO6
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal recessive nonsyndromic hearing loss 37 |
| RS121912559 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS121912560 |
MYO6
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome |
| RS121912561 |
MYO6
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 22, Rare genetic deafness |
| RS121912562 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autism spectrum disorder |
| RS121912563 |
NR3C2
|
Health Risk |
Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912564 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912565 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912566 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912567 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912568 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912569 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Pseudohyperaldosteronism type 2 |
| RS121912570 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912571 |
NR3C2
|
Health Risk |
Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912572 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912573 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912574 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS121912575 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Cardiovascular phenotype |
| RS121912576 |
SMAD4
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Carcinoma of pancreas |
| RS121912577 |
SMAD4
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Carcinoma of pancreas |
| RS121912578 |
SMAD4
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Carcinoma of pancreas |
| RS121912579 |
SMAD4
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Carcinoma of pancreas |
| RS121912580 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS121912581 |
SMAD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, Juvenile polyposis syndrome |
| RS121912582 |
EPHB2
|
Health Risk |
Pathogenic |
Prostate cancer/brain cancer susceptibility, Prostate cancer/brain cancer susceptibility |
| RS121912583 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS121912584 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, Pigmentary skin disorders |
| RS121912585 |
KIF21A
|
Health Risk |
Pathogenic |
Congenital fibrosis of extraocular muscles type 1, Fibrosis of extraocular muscles |
| RS121912586 |
KIF21A
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS121912587 |
KIF21A
|
Health Risk |
Pathogenic |
Congenital fibrosis of extraocular muscles type 1, Congenital fibrosis of extraocular muscles type 1 |
| RS121912588 |
KIF21A
|
Health Risk |
Pathogenic |
Congenital fibrosis of extraocular muscles type 1, Congenital fibrosis of extraocular muscles type 1 |
| RS121912589 |
KIF21A
|
Health Risk |
Pathogenic |
Congenital fibrosis of extraocular muscles type 1, Congenital fibrosis of extraocular muscles type 1 |
| RS121912590 |
KIF21A
|
Health Risk |
Likely pathogenic |
Congenital fibrosis of extraocular muscles type 1, Inborn genetic diseases |
| RS121912591 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS121912592 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS121912593 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS121912595 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS121912596 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS121912597 |
SLC9A9
|
Health Risk |
risk factor |
Autism, susceptibility to |
| RS121912598 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS121912599 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome |
| RS121912600 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome |
| RS121912601 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS121912602 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS121912603 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS121912604 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS121912605 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS121912606 |
ARL13B
|
Health Risk |
Pathogenic |
Joubert syndrome 8, Joubert syndrome 8 |
| RS121912607 |
ARL13B
|
Health Risk |
Pathogenic |
Joubert syndrome 8, Joubert syndrome 8 |
| RS121912608 |
ARL13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 8, Joubert syndrome and related disorders |
| RS121912612 |
SI
|
Health Risk |
Pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS121912613 |
SI
|
Health Risk |
Pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS121912614 |
SI
|
Health Risk |
Pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS121912615 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, SI-related disorder |
| RS121912616 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Inborn genetic diseases |
| RS121912618 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, Wolfram syndrome 1 |
| RS121912619 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, SKIN/HAIR/EYE PIGMENTATION 5 |
| RS121912620 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS121912621 |
SLC45A2
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS121912622 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS121912623 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS121912624 |
TRPM6
|
Health Risk |
Pathogenic/Likely pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS121912625 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS121912626 |
CRELD1
|
Health Risk |
risk factor |
Atrioventricular septal defect, susceptibility to |
| RS121912627 |
CRELD1
|
Health Risk |
risk factor |
Atrioventricular septal defect, susceptibility to |
| RS121912628 |
RAD50
|
Health Risk |
Pathogenic |
Nijmegen breakage syndrome-like disorder, Hereditary cancer-predisposing syndrome |
| RS121912629 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Nijmegen breakage syndrome-like disorder, Hereditary cancer-predisposing syndrome |
| RS121912630 |
IRAK3
|
Health Risk |
risk factor |
Asthma-related traits, susceptibility to |
| RS121912631 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 37, Retinitis pigmentosa |
| RS121912632 |
TRPV4
|
Health Risk |
Pathogenic |
Brachyrachia (short spine dysplasia), Skeletal dysplasia |
| RS121912633 |
TRPV4
|
Health Risk |
Pathogenic/Likely pathogenic |
Brachyrachia (short spine dysplasia), Skeletal dysplasia |
| RS121912634 |
TRPV4
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia, Kozlowski type |
| RS121912635 |
TRPV4
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS121912636 |
TRPV4
|
Health Risk |
Pathogenic |
Metatropic dysplasia, Skeletal dysplasia |
| RS121912637 |
TRPV4
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Maroteaux type |
| RS121912638 |
NDUFS8
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 2 |
| RS121912639 |
NDUFS8
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 2 |
| RS121912641 |
LHX4
|
Health Risk |
Pathogenic |
Short stature-pituitary and cerebellar defects-small sella turcica syndrome, Short stature-pituitary and cerebellar defects-small sella turcica syndrome |